681 related articles for article (PubMed ID: 26501105)
21. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
[TBL] [Abstract][Full Text] [Related]
22. ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment.
Akao H; Polisecki E; Schaefer EJ; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Packard C; Buckley BM; Kajinami K;
Atherosclerosis; 2014 Jul; 235(1):176-81. PubMed ID: 24854628
[TBL] [Abstract][Full Text] [Related]
23. Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation.
Choi KH; Seo WK; Park MS; Kim JT; Chung JW; Bang OY; Kim GM; Song TJ; Kim BJ; Heo SH; Jung JM; Oh KM; Kim CK; Yu S; Park KY; Kim JM; Park JH; Choi JC; Hwang YH; Kim YJ
J Am Heart Assoc; 2019 Dec; 8(24):e013941. PubMed ID: 31826725
[TBL] [Abstract][Full Text] [Related]
24. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.
Nakamura H; Arakawa K; Itakura H; Kitabatake A; Goto Y; Toyota T; Nakaya N; Nishimoto S; Muranaka M; Yamamoto A; Mizuno K; Ohashi Y;
Lancet; 2006 Sep; 368(9542):1155-63. PubMed ID: 17011942
[TBL] [Abstract][Full Text] [Related]
25. Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack.
Lalouschek W; Lang W; Greisenegger S; Müllner M;
Stroke; 2003 Jan; 34(1):105-10. PubMed ID: 12511759
[TBL] [Abstract][Full Text] [Related]
26. Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient).
Yoshimura S; Uchida K; Daimon T; Takashima R; Kimura K; Morimoto T;
Stroke; 2017 Nov; 48(11):3057-3063. PubMed ID: 29030478
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.
Hague WE; Simes J; Kirby A; Keech AC; White HD; Hunt D; Nestel PJ; Colquhoun DM; Pater H; Stewart RA; Sullivan DR; Thompson PL; West M; Glasziou PP; Tonkin AM;
Circulation; 2016 May; 133(19):1851-60. PubMed ID: 27016105
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein levels and outcomes after statin therapy.
Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
[TBL] [Abstract][Full Text] [Related]
29. High-dose atorvastatin after stroke or transient ischemic attack.
Amarenco P; Bogousslavsky J; Callahan A; Goldstein LB; Hennerici M; Rudolph AE; Sillesen H; Simunovic L; Szarek M; Welch KM; Zivin JA;
N Engl J Med; 2006 Aug; 355(6):549-59. PubMed ID: 16899775
[TBL] [Abstract][Full Text] [Related]
30. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
Sasaki S; Nakagawa M; Nakata T; Azuma A; Sawada S; Takeda K; Asayama J;
Circ J; 2002 Jan; 66(1):47-52. PubMed ID: 11999665
[TBL] [Abstract][Full Text] [Related]
31. Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.
Prats-Sanchez L; Camps-Renom P; Nash PS; Wilson D; Ambler G; Best JG; Guasch-Jiménez M; Ramos-Pachón A; Martinez-Domeño A; Lambea-Gil Á; Díaz GE; Guisado-Alonso D; Du H; Al-Shahi Salman R; Jäger HR; Lip GY; Ay H; Jung S; Bornstein NM; Gattringer T; Eppinger S; van Dam-Nolen DH; Koga M; Toyoda K; Fluri F; Phan TG; Srikanth VK; Heo JH; Bae HJ; Kelly PJ; Imaizumi T; Staals J; Köhler S; Yakushiji Y; Orken DN; Smith EE; Wardlaw JM; Chappell FM; Makin SD; Mas JL; Calvet D; Bordet R; Chen CP; Veltkamp R; Kandiah N; Simister RJ; De Leeuw FE; Engelter ST; Peters N; Soo YO; Zietz A; Hendrikse J; Mess WH; Werring DJ; Marti-Fabregas J;
Neurology; 2024 Apr; 102(7):e209173. PubMed ID: 38471056
[TBL] [Abstract][Full Text] [Related]
32. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators.
Flaker GC; Warnica JW; Sacks FM; Moyé LA; Davis BR; Rouleau JL; Webel RR; Pfeffer MA; Braunwald E
J Am Coll Cardiol; 1999 Jul; 34(1):106-12. PubMed ID: 10399998
[TBL] [Abstract][Full Text] [Related]
33. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.
Tonelli M; Moyé L; Sacks FM; Kiberd B; Curhan G;
Ann Intern Med; 2003 Jan; 138(2):98-104. PubMed ID: 12529091
[TBL] [Abstract][Full Text] [Related]
34. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
35. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
36. Statins after ischemic stroke of undetermined etiology in young adults.
Putaala J; Haapaniemi E; Kaste M; Tatlisumak T
Neurology; 2011 Aug; 77(5):426-30. PubMed ID: 21810695
[TBL] [Abstract][Full Text] [Related]
37. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
[TBL] [Abstract][Full Text] [Related]
38. Subsequent vascular events after ischemic stroke: the Japan Statin Treatment Against Recurrent Stroke-Longitudinal.
Nomura E; Suzuki A; Inoue I; Nakagawara J; Takahashi K; Takahashi T; Manabe Y; Yokota C; Okada K; Nishihara T; Yamamoto Y; Noda K; Takahashi S; Ibayashi S; Takagi M; Kitagawa K; Tanahashi N; Kuriyama M; Hirata K; Hosomi N; Minematsu K; Kobayashi S; Matsumoto M;
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):473-9. PubMed ID: 25447211
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
[TBL] [Abstract][Full Text] [Related]
40. Preadmission statin use does not improve functional outcomes or prevent delayed ischemic events in patients with spontaneous subarachnoid hemorrhage.
Lizza BD; Kosteva A; Maas MB; Rosenberg NF; Liotta E; Guth J; Levasseur-Franklin KE; Naidech AM
Pharmacotherapy; 2014 Aug; 34(8):811-7. PubMed ID: 24807391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
